Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,077
Employees1,077
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,077
Employees1,077

EXEL Key Statistics

Market cap
16.70B
Market cap16.70B
Price-Earnings ratio
20.56
Price-Earnings ratio20.56
Dividend yield
—
Dividend yield—
Average volume
3.16M
Average volume3.16M
High today
$69.99
High today$69.99
Low today
$67.29
Low today$67.29
Open price
$68.50
Open price$68.50
Volume
383.46K
Volume383.46K
52 Week high
$73.69
52 Week high$73.69
52 Week low
$39.71
52 Week low$39.71

Stock Snapshot

The current Exelixis(EXEL) stock price is $68.44, with a market capitalization of 16.7B. The stock trades at a price-to-earnings (P/E) ratio of 20.56.

During the trading session on 2026-11-06, Exelixis(EXEL) shares reached a daily high of $69.99 and a low of $67.29. At a current price of $68.44, the stock is +1.7% higher than the low and still -2.2% under the high.

Trading volume for Exelixis(EXEL) stock has reached 383.46K, versus its average volume of 3.16M.

Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $73.69 and a low of $39.71.

Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $73.69 and a low of $39.71.

EXEL News

Investing.com 1d
Exelixis Inc stock hits all-time high at 73.49 USD - Investing.com

...

Exelixis Inc stock hits all-time high at 73.49 USD - Investing.com
Simply Wall St 6d
Earnings Beat Might Change The Case For Investing In Exelixis Stock

Exelixis reported third quarter 2026 revenue of US$658.7 million and net income of US$218.1 million, with earnings per share from continuing operations above th...

Simply Wall St 7d
Exelixis Stock Extends Rally As Q3 Earnings Lift Margins

Exelixis came into Friday already on a strong run, and the stock then jumped another 4.7% to close at $69.34 once investors digested its Q3 2026 report. At firs...

Analyst ratings

58%

of 19 ratings
Buy
31.6%
Hold
57.9%
Sell
10.5%

More EXEL News

Simply Wall St 7d
Exelixis Stock Could Be Below Fair Value On Earnings

has seen its earnings come into sharper focus after a powerful multi year share price run, which raises a straightforward question for you as an investor. Is th...

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.